Analysis of KIR2D receptors on peripheral blood lymphocytes from liver graft recipients

Transplant Immunology

Volumn 17, Issue 1, 2006, Pages 51-54

  López Álvarez, María R ^a   Gómez Mateo, Jorge ^a   Ruiz Merino, Guadalupe ^a   Campillo, José A ^a   Miras, Manuel ^a   García Alonso, Ana M ^a   Sánchez Bueno, Francisco ^a   Parrilla, Pascual ^a   Álvarez López, María R ^a   Minguela, Alfredo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Acute rejection; CD158; KIR receptors; Liver transplantation; NK; T cells

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; BILIRUBIN; CD3 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE 2 D RECEPTOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ACUTE GRAFT REJECTION; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ANTIGEN EXPRESSION; ARTICLE; BILIRUBIN BLOOD LEVEL; BOLUS INJECTION; CD8+ T LYMPHOCYTE; COMPARATIVE STUDY; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER GRAFT; LIVER GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER T CELL; PATIENT ASSESSMENT; PATIENT MONITORING; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STAINING; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TISSUE SECTION;

ACUTE DISEASE; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT REJECTION; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LIVER TRANSPLANTATION; LYMPHOCYTES; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS;

EID: 37849188615     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.09.015     Document Type: Article

References (19)

1. Markus B.H., Duquesnoy R.J., Gordon R.D., Fung JJ., Vanek M., Klintmalm G., et al. Histocompatibility and liver transplant outcome: does HLA exert a dualistic effect?. Transplantation 46 3 (1988) 372-377
2. Nikaein A., Backman L., Jennings L., Levy MF., Goldstein R., Gonwa T., et al. HLA compatibility and liver transplant outcome. Transplantation 58 (1994) 786-792
3. Ontanon J., Muro M., Garcia-Alonso A.M., Minguela A., Torio A., Bermejo J., et al. Effect of partial HLA-Class I match on acute rejection in viral pre-infected human liver allograft recipients. Transplantation 65 (1998) 1047-1053
4. Fungi J.J., Peeve A., Stars T.E., Demerits J., Watseka S., and Duquesnoy R.J. Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol 16 2 (1986) 182-199
5. Oertel M., Kohlhaw K., Diepolder H.M., Schröder S., Schwarz R., Tannapfel A., et al. Alloreactivity of natural killer cells in allogeneic liver transplantation. Transplantation 72 (2001) 116-122
6. Bishara A., Brautbar C., Zamir G., Eid A., and Safadi R. Impact of HLA-C and Bw epitopes disparity on liver ransplantation outcome. Hum Immunol 66 (2005) 1099-1105
7. Mandelboim O., Reyburn H.T., Vales-Gomez M., Pazmany L., Colonna M., Borsellino G., et al. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med 184 (1996) 913-922
8. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5 (2005) 201-214
9. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik WD., Tosti A., et al. Effectiveness of donor natural killer cells alloreactivity in mismatched hematopoietic transplant. Science 295 (2002) 2097-2100
10. Parham P., and McQueen K.L. Alloreactive killer cells hindrance and help for haematopoietic transplants. Nat Rev Immunol 3 (2003) 108-122
11. Moya-Quiles M.R., Muro M., Torio A., Sanchez-Bueno F., Miras M., Marin L., et al. Human leukocyte antigen-C in short and long-term liver graft acceptance. Liver Transplant 9 (2003) 218-227
12. Shilling H.G., McQueen K.L., Cheng N.W., Shizuru JA., Negrin RS., and Parham P. Reconstitution of NK cells repertoire following HLA-matched hematopoietic cell transplantation. Blood 101 (2003) 3730-3740
13. Leung W., Iyengar R., Triplett B., Turner V., Behm FG., Holladay MS., et al. Comparisons of killer Ig-like receptor genotyping and phenotyping for selection of allogenic blood stem cell donors. J Immunol 174 (2005) 6540-6545
14. Kang N., Guan D., Xing N., and Xia C. Expression of CD158b on peripheral blood lymphocytic cell after kidney transplantation. Transplant Proc 37 2 (2005) 782-784
15. Becker S., Tonn T., Fussel T., Uhrberg M., Bogdanow M., Seifried E., et al. Assessment of killer cell immunoglobulin-like receptor expression and corresponding HLA class I phenotypes demonstrates heterogeneous KIR expression independent of anticipated HLA class I ligands. Hum Immunol 64 (2003) 183-193
16. Shilling H.G., Young N., Guethlein L.A., Cheng NW., Gardiner CM., Tyan D., et al. Genetic control of human NK cell repertoire. J Immunol 169 (2002) 239-247
17. Guerra N., Michel F., Gati A., Gaudin C., Mishal Z., Escudier B., et al. Engagement of the inhibitory receptor CD158a interrupts TcR signals, preventing dynamic membrane reorganization in CTL/tumor cell interaction. Blood 100 8 (2002) 2874-2881
18. + T cells. Nat Immunol 2 (2001) 430-435
19. Minguela A., Torio A., Marin L., Muro M., Villar LM., Diaz J., et al. Implication of soluble and membrane HLA class I and serum IL-10 in liver graft acceptance. Hum Immunol 60 (1999) 500-509